Global GMP Network The company operates a global network of harmonized GMP laboratories across 59 countries with 2 million square feet of capacity, enabling scalable testing for multinational pharma and medical device clients. This suggests a strong opportunity to upsell cross-border testing services and centralized quality programs for global product launches.

End-to-End Testing Offers testing across drug substance, intermediates, starting materials, and final products under GMP with ISO 17025 and ISO 9000, aligned to Ph. Eur., BP, USP, and JP. This positions as a one-stop partner for clients seeking comprehensive testing pipelines, enabling upsell of integrated method validation and reference standards.

US Presence Seven key US sites provide personalized service with access to a global capabilities network. This mix presents a chance to target mid-size and large US-based pharma/biotech firms for regional testing contracts while leveraging global harmonization for their international programs.

Digital Access Secure 24-hour data access via LabAccess.com supports real-time data sharing and project transparency. This can be a selling point for sponsors requiring rapid data turnaround, audit trails, and remote collaboration, opening doors for long-term managed services.

Strategic Partnerships Recent partnerships and acquisitions in testing and environmental sectors indicate an active expansion roadmap. Engage with Eurofins QTA and related units for collaboration on specialized testing, LIMS enhancements, and combined service offerings to broaden credentialed capabilities for high-demand segments.